Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tevogen Bio Holdings Inc. | Chief Scientific Officer, Global R&D Lead | Common Stock | 3.6M | $3.92M | $1.09 | Mar 12, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TVGN | Tevogen Bio Holdings Inc. | Mar 12, 2025 | 1 | -$254K | 4 | Mar 14, 2025 | Chief Scientific Officer, Global R&D Lead |
TVGN | Tevogen Bio Holdings Inc. | Mar 7, 2025 | 3 | -$232K | 4 | Mar 11, 2025 | Chief Scientific Officer, Global R&D Lead |
TVGN | Tevogen Bio Holdings Inc. | Mar 4, 2025 | 3 | -$250K | 4 | Mar 6, 2025 | Chief Scientific Officer, Global R&D Lead |
TVGN | Tevogen Bio Holdings Inc. | Oct 17, 2024 | 1 | -$1.75M | 4 | Oct 18, 2024 | Chief Scientific Officer, Global R&D Lead |
TVGN | Semper Paratus Acquisition Corp | Feb 14, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Scientific Officer |
TVGN | Semper Paratus Acquisition Corp | Feb 14, 2024 | 0 | $0 | 3 | Feb 16, 2024 | Chief Scientific Officer |